ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
광역학 요법(PDT) 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.0%로 19억 3,000만 달러에 달할 전망입니다. 예측 기간의 성장은 의료비 지출 증가, 광역학 요법(PDT)의 보험 적용, 신흥국의 높은 잠재력, 10대 인구 증가, 노인 인구 증가, 암 및 만성 질환의 유병률 증가, 감염성 질환의 출현 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 가정 내 피부과적 PDT 치료에 도움이 되는 휴대용 광역학 요법(PDT) 장치의 도입, 환자 치료 개선을 위한 인공지능 지원 PDT에 대한 투자, 미용 시술 분야의 제품 포트폴리오 확대, 연구개발에 대한 지속적인 투자, 광면역 치료 장치 제공에 집중, 광열 요법을 포함한 포트폴리오 확대 등이 있습니다. 광열요법을 포함한 포트폴리오 확대 등을 꼽을 수 있습니다.
향후 5년간 6.0%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 캐나다와 프랑스에서 수입되는 아미노레불린산과 같은 광증감제 및 특수 광시스템의 비용을 상승시켜 첨단 광선각화증 및 피부암 치료에 대한 접근성을 떨어뜨릴 수 있기 때문에 피부과 센터에 장애가 될 것으로 예측됩니다. 또한, 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
피부암 발병률 증가가 광역학 요법(PDT) 시장의 성장을 주도하고 있습니다. 피부암은 가장 흔한 암으로 인식되고 있으며, 흑색종은 전체 암 발생의 약 1%를 차지하지만, 피부암과 관련된 사망자 수는 매우 많습니다. PDT는 암세포를 표적으로 삼아 파괴하기 위해 강한 빛과 결합된 감광제를 사용합니다. 이 과정은 보통 의사가 피부암과 그 주변에 감광제를 함유한 로션을 바르는 것으로 시작됩니다. 예를 들어, 2024년 1월, 미국에 본부를 둔 전문 기관인 미국 암 협회는 피부암이 미국에서 가장 발병률이 높은 암이며, 흑색종은 1%에 불과하지만 피부암으로 인한 사망자의 대부분을 차지한다고 보고했습니다. 또한, 2024년에는 미국에서 약 10만 640명이 새로 흑색종 진단을 받을 것으로 예상되며, 남성은 약 5만 9170명, 여성은 약 4만 1470명이 발병할 것으로 추정됩니다. 흑색종으로 인한 사망자 수는 약 8,290명으로 예상되며, 그 중 남성은 약 5,430명, 여성은 약 2,860명입니다. 그 결과, 피부암 유병률 증가는 향후 몇 년 동안 광역학 요법(PDT) 시장의 성장을 크게 촉진할 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나19와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 광역학 요법(PDT) : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 광역학 요법(PDT) 시장 : 성장률 분석
세계의 광역학 요법(PDT) 시장 실적 : 규모와 성장, 2019-2024
세계의 광역학 요법(PDT) 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 광역학 요법(PDT) : 총잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 광역학 요법(PDT) 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
약물
디바이스
세계의 광역학 요법(PDT) 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
광선각화증(AK)
암
여드름
건선
기타 용도
세계의 광역학 요법(PDT) 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
화장품 및 피부과 클리닉
병원
암 치료센터
기타 최종사용자
세계의 광역학 요법(PDT) 시장 : 약물 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
광감작제
병용 약물 요법
신규 광감작제 제형
세계의 광역학 요법(PDT) 시장 : 디바이스 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
광원(레이저 시스템, LED 시스템)
유통 디바이스(광섬유, 핸드헬드 디바이스)
치료 시스템(휴대용 디바이스, 고정 시스템)
제7장 지역별/국가별 분석
세계의 광역학 요법(PDT) 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 광역학 요법(PDT) 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
광역학 요법(PDT) 시장 : 경쟁 구도
광역학 요법(PDT) 시장 : 기업 개요
Galderma S.A. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bausch Health : 개요, 제품 및 서비스, 전략 및 재무 분석
Lumenis Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sun Pharmaceutical Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Biofrontera : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Modlight Inc.
PhotoMedex Inc.
Soligenix Inc.
Quest PharmaTech Inc.
Novartis AG
Theralase Technologies Inc.
Quantel Medical
Axcan Pharma
Sihealth
MediGlobus
Steba Biotech
Ambicare Health
Nuovo Therapy
Pharmstandard
Rusatom Healthcare
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
광역학 요법(PDT) 시장(2029년) : 새로운 기회를 제공하는 국가
광역학 요법(PDT) 시장(2029년) : 새로운 기회를 제공하는 부문
광역학 요법(PDT) 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Photodynamic therapy (PDT) is a procedure that involves using a light source and light-sensitive medication to eliminate abnormal cells. It is applied in the treatment of certain eye and skin disorders, as well as specific types of cancers. PDT is a two-stage treatment process that combines light energy with a light-activated drug (photosensitizer) designed to destroy cancerous and precancerous cells.
The primary product categories in the photodynamic therapy market are drugs and devices. PDT drugs are light-sensitive substances that, when activated by specific types of light, work to destroy abnormal cells for the treatment of various diseases. PDT devices include lamps, LED devices, and other light-emitting devices used to activate PDT drugs. Photodynamic therapy finds applications in treating diseases such as acne, actinic keratosis, cancer, and psoriasis, among others. It is employed in various sectors, including cosmetics and dermatology clinics, hospitals, cancer treatment centers, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The photodynamic therapy market research report is one of a series of new reports from The Business Research Company that provides photodynamic therapy market statistics, including photodynamic therapy industry global market size, regional shares, competitors with a photodynamic therapy market share, detailed photodynamic therapy market segments, market trends and opportunities, and any further data you may need to thrive in the photodynamic therapy industry. This photodynamic therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The photodynamic therapy market size has grown strongly in recent years. It will grow from $1.45 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to an aging population pool, an increase in cancer prevalence, an increase in skin diseases, rising pollution rates, increased healthcare expenditure, and growth in the number of healthcare facilities.
The photodynamic therapy market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to the rise in healthcare expenditure, insurance coverage for photodynamic therapy, high potential in emerging economies, increasing teenage population, increasing older population, increasing prevalence of cancer and chronic diseases, and the emergence of infectious diseases. Major trends in the forecast period include the introduction of a portable photodynamic therapy device that helps in at-home dermatological PDT treatments, investing in artificial intelligence-enabled PDT for improved treatment of patients, expanding the product portfolio in cosmetic procedures, continuing investment in research and development, focusing at providing photoimmunotherapy devices and expand the portfolio to include photothermal therapy.
The forecast of 6.0% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper dermatology centers by increasing costs of photosensitizing agents like aminolevulinic acid and specialized light systems imported from Canada and France, potentially reducing access to advanced actinic keratosis and skin cancer treatments. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of skin cancer is driving the growth of the photodynamic therapy (PDT) market. Skin cancer is recognized as the most common form of cancer, with melanoma accounting for about 1% of cases but leading to a significant number of skin cancer-related deaths. PDT involves using a light-sensitizing medication combined with intense light to target and destroy cancer cells. This process typically begins with a doctor applying a lotion containing the light-sensitizing agent to the skin cancer and its surrounding area. For example, in January 2024, the American Cancer Society, a U.S.-based professional organization, reported that skin cancer is the most prevalent cancer in the U.S. Melanoma, while only 1% of cases, is responsible for the majority of skin cancer fatalities. Additionally, it is estimated that in 2024, there will be about 100,640 new melanoma diagnoses in the U.S., with approximately 59,170 cases in men and 41,470 in women. Around 8,290 deaths from melanoma are projected, including about 5,430 men and 2,860 women. Consequently, the increasing prevalence of skin cancer is anticipated to significantly boost the growth of the photodynamic therapy market in the coming years.
The rising healthcare expenditure is anticipated to boost the growth of the photodynamic therapy (PDT) market in the future. Healthcare expenditure encompasses the total funds allocated for healthcare goods and services, including medical equipment, hospital services, physician services, prescription drugs, and public health initiatives. This expenditure is vital for advancing photodynamic therapy as it facilitates research, education, infrastructure development, and patient access. For instance, in June 2024, The King's Fund, a UK-based non-profit organization, reported that in 2022/23, the Department for Health and Social Care allocated £182 billion ($227.5 billion) to support various health and care services, including GP services, ambulance services, mental health, community care, and hospital care. Furthermore, the budget for the 2024/25 period is projected to increase to £192 billion ($240 billion), reflecting a rise of £1.1 billion ($1.375 billion) from the previous year, even after accounting for inflation. This funding is aimed at enhancing the quality and accessibility of health services, indicating a strong commitment to improving healthcare resources. Therefore, the growing healthcare expenditure is driving the expansion of the photodynamic therapy market.
Key players in the photodynamic therapy (PDT) market are increasingly emphasizing clinical trials that explore the combination of PDT with various drugs. For example, in February 2024, Kintara Therapeutics, a US-based biotechnology company, announced the launch of a clinical trial for its REM-001 therapy, which targets cutaneous metastatic breast cancer. The clinical trial, identified as NCT05374915, is an open-label study involving 15 patients diagnosed with cutaneous metastatic breast cancer (CMBC). It aims to evaluate the efficacy of the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The trial seeks to refine the study design in preparation for a Phase 3 trial and focuses on the Best Overall Objective Response Rate (bORR) in treatment fields over a 24-week period. The primary endpoints include the assessment of complete and partial responses to the treatment.
Artificial intelligence models have demonstrated significant potential in the diagnosis and treatment of cancer. There is an increasing trend in funding aimed at enhancing product design and clinical testing, particularly in the realm of artificial intelligence applications in photodynamic therapy (PDT). AI is being utilized to examine pain and outcomes for superficial basal cell carcinomas and other diseases treated with PDT. For example, in June 2024, Biofrontera Inc., a biopharmaceutical company based in the US, introduced its FDA-approved RhodoLED XL lamp for the treatment of actinic keratosis. The FDA has authorized a new device to be used in conjunction with aminolevulinic acid hydrochloride topical gel (Ameluz) as a PDT option for mild-to-moderate actinic keratoses on the face and scalp. The RhodoLED XL commenced commercial distribution in June 2024, showcasing the company's dedication to innovation in dermatology. Its user-friendly design and features are intended to improve patient care and may set a new benchmark for PDT. The announcement emphasized the considerable advancements this lamp provides for the treatment of actinic keratosis, the most prevalent pre-cancerous skin condition.
In February 2023, Omni Partners LLP, a UK-based investment management firm, finalized the acquisition of Aesthetic Technology Ltd for an undisclosed sum. This acquisition is part of Omni Partners' strategy to enhance new technologies in healthcare, particularly those that offer effective solutions for aesthetic and medical treatments. Aesthetic Technology Limited is a UK-based manufacturer of medical equipment, focusing on innovative energy-based devices for the medical, aesthetic, and cosmetic sectors.
Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Industria e Comercio de ProdutosFarmaceuticos, MMOptics Ltd, Global Healthcare Solutions Peru, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.
North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the photodynamic therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The photodynamic therapy market includes revenues earned by entities by treating actinic keratoses and superficial basal cell carcinomas. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Photodynamic Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on photodynamic therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for photodynamic therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The photodynamic therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Drugs, Devices
2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications
3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users
Subsegments:
1) By Drugs: Photosensitizers; Combination Drug Therapies; Novel Photosensitizer Formulations
2) By Devices: Light Sources (Laser Systems, LED Systems); Delivery Devices (Fiber Optics, Handheld Devices); Treatment Systems (Portable Devices, Fixed Systems)
Companies Mentioned: Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera; Modlight Inc.; PhotoMedex Inc.; Soligenix Inc.; Quest PharmaTech Inc.; Novartis AG; Theralase Technologies Inc.; Quantel Medical; Axcan Pharma; Sihealth; MediGlobus; Steba Biotech; Ambicare Health; Nuovo Therapy; Pharmstandard; Rusatom Healthcare; Roche Latvija SIA; Hologic, Inc.; Dusa Pharmaceuticals; PDT Pharma Industria e Comercio de ProdutosFarmaceuticos; MMOptics Ltd; Global Healthcare Solutions Peru; DMC Equipmentos LTDA; Biolite; SyMed LLC; Alma Lasers; Candela Medica; Velt International Group Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Photodynamic Therapy Market Characteristics
3. Photodynamic Therapy Market Trends And Strategies
4. Photodynamic Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Photodynamic Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Photodynamic Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Photodynamic Therapy Market Growth Rate Analysis
5.4. Global Photodynamic Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Photodynamic Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Photodynamic Therapy Total Addressable Market (TAM)
6. Photodynamic Therapy Market Segmentation
6.1. Global Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drugs
Devices
6.2. Global Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Actinic Keratosis (AK)
Cancer
Acne
Psoriasis
Other Applications
6.3. Global Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cosmetics And Dermatology Clinics
Hospitals
Cancer Treatment Centers
Other End-Users
6.4. Global Photodynamic Therapy Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Photosensitizers
Combination Drug Therapies
Novel Photosensitizer Formulations
6.5. Global Photodynamic Therapy Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Light Sources (Laser Systems, LED Systems)
Delivery Devices (Fiber Optics, Handheld Devices)
Treatment Systems (Portable Devices, Fixed Systems)
7. Photodynamic Therapy Market Regional And Country Analysis
7.1. Global Photodynamic Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Photodynamic Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
